Skip to main navigation Skip to search Skip to main content

Point-of-care coagulation testing for obstetric hemorrhage

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Postpartum hemorrhage (PPH) is a leading cause of maternal morbidity and mortality worldwide. Multiple etiologies exist for PPH, both surgical and nonsurgical. One such nonsurgical etiology is either an underlying or a developing hemostatic impairment, which may also exacerbate bleeding due to other causes. Specific causes of coagulopathy in massive obstetric bleeding include hyperfibrinolysis, dilutional coagulopathy due to volume resuscitation, or consumptive coagulopathy. Though central laboratory coagulation studies are reliable and accurate, they may take too long to result (especially at a busy tertiary center, >60min), while the coagulation in patients with PPH may be dynamic and unstable. In this chapter, we will introduce the concept of point-of-care coagulation testing including viscoelastic tests and provide clinicians with timely data to guide blood product transfusion.

Original languageEnglish
Title of host publicationPharmacology, Physiology, and Practice in Obstetric Anesthesia
PublisherElsevier
Pages491-497
Number of pages7
ISBN (Electronic)9780443217074
ISBN (Print)9780443217067
DOIs
StatePublished - 1 Jan 2025

Keywords

  • Hypofibrinogenemia
  • Obstetric hemorrhage
  • Point-of-care coagulation testing
  • ROTEM
  • TEG
  • Viscoelastic hemostatic assays

Fingerprint

Dive into the research topics of 'Point-of-care coagulation testing for obstetric hemorrhage'. Together they form a unique fingerprint.

Cite this